Appraiser seen from behind writing in a ledger beside an old hardcover book in a bright library workroom.

What happens when intellectual property built into your products turns out to belong to someone else? This week supplied three expensive answers. Each involved one of the world’s most powerful companies...

A row of identical clear glass objects fading into shadow, with one solid stone object in sharp focus at the front.

Something quietly broke this year in one of Silicon Valley’s most-watched classrooms. In Steve Blank’s 2026 Lean LaunchPad at Stanford, every team used AI to spin up working products in hours...

An engineer in a hi-vis vest looks down from a walkway at the lit concrete foundations of a construction site at dusk.

The most valuable intellectual property in your business is often not the product your customers see — it’s the platform underneath it: the data it learned from, the delivery technology it...

Book titled 'IP Playbook: Strategies for Intellectual Property' floating in space with galaxy and Earth in background

Ben Thompson’s recent Stratechery analysis is a masterclass in how scale, integration and narrative compound into something competitors can no longer touch. Starlink is profitable not because the satellites are clever,...

A hand moves an amber-lit game piece across a glowing frosted-glass map table, illustrating IP strategy scenario planning.

Most companies now accept that geopolitical risk belongs in corporate strategy, yet very few have ever stress-tested how they would actually respond. McKinsey’s recent article, The art, science, and technology of...

Clear unlabelled spirit bottle on terracotta earth with a sunlit coastal vineyard blurred behind it.

If your product’s value lives in where it comes from — a region, a method, a 450-year tradition — the hardest question in your IP strategy is whether the law will...

Two race cars labeled Brand Name Pharma and Generic Competition racing on track near a sign reading Patent Expiration Ahead and a cliff labeled The Drug Patent Cliff

IP Organiser’s recently compiled record of every pharmaceutical patent term extension granted in Australia maps roughly 1,600 extended patents across 850 products, and the patterns are worth reading closely. Activity is...

Professional using advanced holographic interface for IP workflow with rocket and icons, office teams in background

The shift toward high‑impact individual contributors (ICs) is more than an organizational design trend. It signals a deeper structural change in how companies create, protect, and compound value. Elena Verna’s piece...

Widening a patent claim is never free. Every limitation you drop to capture more of the market quietly commits you to two things: a disclosure that actually supports the wider claim,...